Screener
Integra LifeSciences IART Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
FAQ
- What is Integra LifeSciences's free cash flow?
- Integra LifeSciences (IART) reported free cash flow of $10.5M in Q2 2026.
- How has Integra LifeSciences's free cash flow changed year-over-year?
- Integra LifeSciences's free cash flow increased by 193.5% year-over-year, from -$11.23M to $10.5M.
- What is the long-term trend for Integra LifeSciences's free cash flow?
- Over 2 years (2021 to 2023), Integra LifeSciences's free cash flow has grown at a -47.4% compound annual growth rate (CAGR), from $264.41M to $73.09M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Integra LifeSciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude